| Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 (NCT05034874) | InterveXion Therapeutics, LLC | 2022-06-09 |
| Inflammation in Methamphetamine and STIs (IMSTI) (NCT05162391) | University of California, Los Angeles | 2022-05-31 |
| PRevention Of Methamphetamine Use Among Postpartum Women Trial (PROMPT) (NCT05128071) | University of Utah | 2022-02-04 |
| rTMS for Stimulant Use Disorders (NCT04907357) | Medical University of South Carolina | 2022-02-04 |
| Contingency Management for PrEP Adherence and/or Methamphetamine Use (NCT04563962) | University of California, Los Angeles | 2021-03-15 |
| Delivering Contingency Management in Outpatient Addiction Treatment (NCT04544124) | University of Calgary | 2021-01-25 |
| Effect of Methamphetamine on Residual Latent HIV Disease Study (NCT03825536) | University of California, San Francisco | 2021-01-01 |
| Pilot TMS for Methamphetamine Use Disorder (NCT04449055) | Ryan M. Carnahan | 2020-10-06 |
| The Human Stress Response in a Simulated ED Setting (NCT04317482) | University of Arkansas | 2020-08-26 |
| Repetitive dTMS Intervention for Methamphetamine Addiction (NCT04202926) | Shanghai Mental Health Center | 2019-12-30 |
| Effects of Genotype on Resting State Connectivity During Methamphetamine Administration (NCT03973489) | Oregon Health and Science University | 2019-08-16 |
| Paired Associative Stimulation in Methamphetamine Addiction (NCT03910608) | Shanghai Mental Health Center | 2019-05-01 |
| Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users (NCT03341078) | VA Office of Research and Development | 2019-05-01 |
| Transcranial Direct Current Stimulation (tDCS) Combined With Computerized Cognitive Addiction Therapy(CCAT) and, Electronic Follow-up for Methamphetamine(MA) Dependent Patients (NCT04139148) | Shanghai Mental Health Center | 2019-02-01 |
| Transcranial Magnetic Stimulation for Treatment of Methamphetamine Dependence (NCT03827785) | Shanghai Mental Health Center | 2019-02-01 |
| Stimulant Use and Methylation in HIV (NCT05916989) | Florida International University | 2018-09-30 |
| Study of Antibody for Methamphetamine Outpatient Therapy (NCT03336866) | InterveXion Therapeutics, LLC | 2018-05-03 |
| rTMS for Craving in Methamphetamine Use Disorder (NCT03470480) | Oregon Health and Science University | 2018-02-07 |
| Creatine for Depressed Male and Female Methamphetamine Users (NCT02568878) | Montana State University | 2015-11-01 |
| Pilot Study of Entacapone for Methamphetamine Abuse (NCT02058966) | Oregon Health and Science University | 2014-06-01 |
| Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence (NCT02034201) | University of Arkansas | 2014-02-01 |
| Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse (NCT01967381) | University of Kentucky | 2013-10-01 |
| Buspirone as a Candidate Medication for Methamphetamine Abuse (NCT01843205) | University of Kentucky | 2013-04-01 |
| A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated Psychosis (NCT01822730) | Wei Hao | 2013-02-01 |
| An Study of Paliperidone Extended-Release Tablets in the Treatment of Methamphetamine Dependence (NCT01825928) | Wei Hao | 2013-02-01 |
| An Study of Aripiprazole in the Treatment of Methamphetamine Dependence (NCT01813656) | Wei Hao | 2012-09-01 |
| A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated Psychosis (NCT01813643) | Wei Hao | 2012-07-01 |
| Clinical Efficacy of Atomoxetine for Methamphetamine Dependence (NCT01557569) | University of Arkansas | 2012-04-01 |
| Comparison of Methamphetamine-Dependent and Healthy Volunteers Using a Web-Enabled Cognitive Neuropsychological Evaluation System (NCT01919437) | California Pacific Medical Center Research Institute | 2012-04-01 |
| A Cognitive Behavioral Therapy-Based Text Messaging Intervention for Methamphetamine Dependence (NCT01577797) | New Leaf Treatment Center | 2012-04-01 |
| Varenicline for Methamphetamine Dependence (NCT01365819) | University of California, Los Angeles | 2012-02-01 |
| A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence (NCT01354470) | California Pacific Medical Center Research Institute | 2011-10-01 |
| PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND) (NCT01377662) | Tong Lee | 2011-08-01 |
| Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study (NCT01359930) | National Institute on Drug Abuse (NIDA) | 2011-08-01 |
| Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/Dependence (NCT01273701) | National Taiwan University Hospital | 2011-01-01 |
| Safety Interaction Trial Ibudilast and Methamphetamine (NCT01217970) | University of California, Los Angeles | 2011-01-01 |
| Methylphenidate to Treat Methamphetamine Dependence (NCT01044238) | University of California, Los Angeles | 2010-10-01 |
| NAC as a Potential Treatment for Methamphetamine Dependence (NCT01063205) | Baylor College of Medicine | 2010-03-01 |
| Smoking-Cessation and Stimulant Treatment (S-CAST) (NCT01077024) | University of Cincinnati | 2010-02-01 |
| Citicoline Treatment of Methamphetamine Dependence (NCT00950352) | Perry Renshaw | 2010-01-01 |
| RTI-336 as a Treatment for Methamphetamine Dependence (NCT01601717) | Baylor College of Medicine | 2010-01-01 |
| Efficacy and Safety of CDP-choline in Patients With Methamphetamine Dependence (NCT01007539) | Seoul National University Hospital | 2009-11-01 |
| Safety Assessment of Atomoxetine With MA IV Administration (NCT01019707) | University of California, Los Angeles | 2009-10-01 |
| Studying Amphetamine Withdrawal in Humans (NCT01215929) | University of Arkansas | 2009-10-01 |
| Study of Naltrexone for Methamphetamine Addiction (NCT00984360) | California Pacific Medical Center Research Institute | 2009-09-01 |
| Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial (NCT00728312) | US Department of Veterans Affairs | 2009-08-01 |
| Rivastigmine as a Treatment for Methamphetamine Dependence (NCT01073319) | Baylor College of Medicine | 2009-07-01 |
| An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence (NCT01062451) | Baylor College of Medicine | 2009-05-01 |
| Modafinil for Methamphetamine Dependence (NCT00859573) | University of Arkansas | 2009-04-01 |
| Intensive Motivational Interviewing for Methamphetamine Dependence (NCT01071356) | Public Health Institute, California | 2009-02-01 |
| Effects of Modafinil in Methamphetamine Dependence (NCT00751023) | Medical University of South Carolina | 2009-02-01 |
| Study of Medical Treatment for Methamphetamine Addiction (NCT00833443) | University of California, Los Angeles | 2009-01-01 |
| Risk and Protective Factors for Rural Methamphetamine Dependence (NCT00882037) | University of Nebraska | 2008-12-12 |
| Transcranial Magnetic Stimulation Used to Both Measure Cortical Excitability and Explore Methamphetamine Cue Craving (NCT01685463) | Medical University of South Carolina | 2008-09-01 |
| Open-Label Disulfiram for Methamphetamine Dependence (NCT00731133) | University of Arkansas | 2008-08-01 |
| Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence (NCT00730522) | Catalyst Pharmaceuticals, Inc. | 2008-07-01 |
| Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence (NCT00687713) | National Institute on Drug Abuse (NIDA) | 2008-05-01 |
| Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH) (NCT00603434) | University of Cincinnati | 2008-01-01 |
| Methamphetamine-Quetiapine Interactions in Humans (NCT00567866) | University of Arkansas | 2008-01-01 |
| Varenicline-Methamphetamine Interaction Study (2008) (NCT00733967) | Baylor College of Medicine | 2008-01-01 |
| Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence (NCT00520286) | National Institute on Drug Abuse (NIDA) | 2007-12-01 |
| Safety and Tolerability of Modafinil for Methamphetamine Dependence (NCT00569374) | University of Arkansas | 2007-09-01 |
| Modafinil vs Placebo for the Treatment of Methamphetamine Dependence (NCT00469508) | University of California, Los Angeles | 2007-04-01 |
| Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study (NCT00653263) | University of Arkansas | 2006-08-01 |
| N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence (NCT00332605) | University of Chicago | 2006-06-01 |
| A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence (NCT00284206) | Seattle Institute for Biomedical and Clinical Research | 2006-01-01 |
| A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence (NCT00227123) | University of Texas Southwestern Medical Center | 2002-10-01 |
| Ph1 Lobeline Interaction Study - 1 (NCT00439504) | National Institute on Drug Abuse (NIDA) | |